航天長峯(600855.SH):預計2024年淨虧損2.25億元到2.68億元
格隆匯1月16日丨航天長峯(600855.SH)公佈,經財務部門初步測算,預計2024年年度實現歸屬於母公司所有者的淨利潤為-22,500萬元到-26,800萬元,與上年同期(法定披露數據)相比,仍將虧損。預計2024年年度實現歸屬於母公司所有者的扣除非經常性損益後的淨利潤為-24,800萬元到-29,100萬元。本報吿期內,公司業績預虧主要原因如下:一是市場競爭較為激烈,市場開拓不及預期,公司整體業務規模下滑;二是由於收入、回款情況不及預期,應收款項和存貨賬齡變長,導致本年計提減值損失較大;三是子公司航天柏克業績不及預期,基於謹慎性判斷,對收購航天柏克形成的商譽計提減值準備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.